Published in Lung Cancer on March 19, 2013
Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer. Chin Med J (Engl) (2017) 0.75
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med (2006) 10.48
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol (2006) 8.53
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol (2011) 2.87
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol (2010) 1.85
Improved capsule endoscopy after bowel preparation. Gastrointest Endosc (2005) 1.71
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. J Thorac Cardiovasc Surg (2010) 1.71
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol (2003) 1.50
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. J Clin Oncol (2010) 1.44
Unnecessary Procedures and Surgery in Autoimmune Pancreatitis. Digestion (2015) 1.43
Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer (2011) 1.39
Chronic abdominal pain: not always irritable bowel syndrome. Dig Dis Sci (2006) 1.39
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg (2006) 1.28
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J Clin Oncol (2004) 1.28
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int J Cancer (2005) 1.19
Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics (2011) 1.17
Endoscopic management of a penetrated gastric band. Gastrointest Endosc (2004) 1.09
Recommendations for a global core curriculum in medical oncology. J Clin Oncol (2004) 1.06
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. J Clin Ultrasound (2008) 1.06
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. J Clin Oncol (2007) 1.04
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program. Clin Cancer Res (2007) 0.99
p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma. Neoplasia (2006) 0.97
Evidence-based oncology in cancer treatment reviews. Cancer Treat Rev (2003) 0.94
Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg (2009) 0.92
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer (2012) 0.92
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. J Thorac Oncol (2014) 0.90
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology. Lung Cancer (2012) 0.90
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med (2013) 0.89
PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg (2008) 0.89
Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol (2013) 0.89
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Rev Anticancer Ther (2013) 0.89
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients. Lung Cancer (2010) 0.89
Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulm Med (2014) 0.89
Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer (2012) 0.88
Impact of comorbidities on physical activity in COPD. Respirology (2015) 0.87
Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clin Proteomics (2013) 0.87
Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer (2012) 0.86
Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis (2011) 0.86
TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Lung Cancer (2008) 0.85
Aggressive lymphoma: improving treatment outcome with rituximab. Anticancer Drugs (2002) 0.85
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer (2012) 0.84
Transnasal endoscopy for the placement of nasoenteral feeding tubes: does the working length of the endoscope matter? Gastrointest Endosc (2007) 0.83
Trimethoprim/Sulfamethoxazole pharmacokinetics in two patients undergoing continuous venovenous hemodiafiltration. Ann Pharmacother (2010) 0.83
Treatment and detection of ALK-rearranged NSCLC. Lung Cancer (2013) 0.82
Hyperferritinemia without iron overload in patients with bilateral cataracts: a case series. J Med Case Rep (2011) 0.81
Complete atrioventricular block in a patient with acute cholecystitis: a case of cardio-biliary reflex? Eur J Emerg Med (2009) 0.81
Successful endoscopic management of gastrointestinal leakages after laparoscopic Roux-en-Y gastric bypass surgery. Dig Surg (2014) 0.80
Kinetics of microRNA Expression in Bronchoalveolar Lavage Fluid Samples. Lung (2015) 0.80
Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. J Thorac Cardiovasc Surg (2011) 0.79
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study. Leuk Lymphoma (2003) 0.79
Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis. Indian J Gastroenterol (2008) 0.79
Iatrogenic Complications in Five Patients with Upper Gastrointestinal Bleeding due to Ambient Air: Case Series and Literature Review. Case Rep Gastroenterol (2012) 0.79
Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature. Dermatology (2013) 0.78
Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer. Eur J Cardiothorac Surg (2011) 0.77
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors. J Clin Oncol (2004) 0.76
Chronic Norovirus Infection as a Risk Factor for Secondary Lactose Maldigestion in Renal Transplant Recipients: A Prospective Parallel Cohort Pilot Study. Transplantation (2017) 0.76
Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer (2011) 0.76
Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. Eur J Pharm Sci (2010) 0.76
Multiple infarcted regenerative nodules in liver cirrhosis after decompensation of cirrhosis: a case series. J Med Case Rep (2010) 0.75
Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines. Medicine (Baltimore) (2015) 0.75
Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma. J Comput Assist Tomogr (2015) 0.75
Liver unidentified bright object in a septic patient. Case Rep Gastroenterol (2013) 0.75
SafAIRway: an airway training for pulmonologists performing a flexible bronchoscopy with nonanesthesiologist administered propofol sedation: A prospective evaluation. Medicine (Baltimore) (2016) 0.75
Biomarker testing in non-small cell lung cancer: to move forward with quality. Clin Transl Oncol (2012) 0.75
[Erythrocytosis]. Praxis (Bern 1994) (2013) 0.75
Severe acute respiratory distress syndrome due to ipilimumab. Eur Respir J (2013) 0.75
Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting. Lung Cancer (2011) 0.75
Anal lesions and suspected sexual abuse in a 17-year-old girl. Swiss Med Wkly (2005) 0.75
[Fever and neutropenia]. Praxis (Bern 1994) (2013) 0.75
Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease? Swiss Med Wkly (2006) 0.75
Towards Individualized Tracheobronchial Stents: Technical, Practical and Legal Considerations. Respiration (2017) 0.75
The way to a man's stomach is through his heart. Gastroenterology (2011) 0.75
Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun (2016) 0.75
Struck dysphagic. Gastroenterology (2009) 0.75
[Inhalation trauma]. Praxis (Bern 1994) (2013) 0.75
[Not a tropical, but a non the less exotic fever]. Praxis (Bern 1994) (2013) 0.75
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation. Swiss Med Wkly (2013) 0.75
[In Process Citation]. Praxis (Bern 1994) (2013) 0.75
Splenic duplication: a rare cause of acute upper gastrointestinal bleeding. Abdom Imaging (2013) 0.75
Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer. Clin Lung Cancer (2008) 0.75
[Mediastinal widening]. Praxis (Bern 1994) (2013) 0.75
[Fatty liver: frequent and not completely harmless]. Praxis (Bern 1994) (2013) 0.75
Takayasu's Arteritis with Isolated Pulmonary Artery Involvement in a Middle-Aged Asian Woman with Hepatitis B and Latent Tuberculosis Infection. Respiration (2017) 0.75
Cancer treatment reviews welcomes submission of the Cochrane Reviews. Cancer Treat Rev (2006) 0.75
[Gestational diabetes]. Praxis (Bern 1994) (2012) 0.75
[(Spontaneous) pneumothorax]. Praxis (Bern 1994) (2013) 0.75
Images in emergency medicine. Cullen's sign and Grey-Turner's sign. Ann Emerg Med (2008) 0.75